Tradeable Event
LIVE
--:--:--
Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.
—
—
—
—
--:--:--
—
Blue Team
50%
Red Team
50%
$0 vol
Loading chart...
PAPER
LIVE
$
Avg price
50¢
Shares
Potential return
$20.00 (+100%)
BLUE TEAM
Blue Team
+0.00%
wins
—
EPOCH WINS
RED TEAM
Red Team
+0.00%
wins
Epoch History
No completed epochs yet
Recent Trades
Waiting for trades...
Event Feed
Monitoring headlines...
Buy Blue Team
$
Avg price
50¢
Shares
Potential return
$20.00 (+100%)